Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
Nelofer Syed(Hammersmith Hospital), Tim Crook(Bupa Cromwell Hospital)
Cited by 169
Related Papers
The p53 pathway in breast cancer
|Breast Cancer Research|2002|396
Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer
|Cancer Research|2011|60
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
|British Journal of Cancer|2010|34
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer
|Oncotarget|2012|33
Integrated systems‐genetic analyses reveal a network target for delaying glioma progression
|Annals of Clinical and Translational Neurology|2019|8